XML 38 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities    
Net loss $ (62,052) $ (41,860)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 174 59
Loss on sale of assets   26
Stock-based compensation expense 8,491 3,049
Remeasurement of convertible preferred stock call option liability   9,560
Remeasurement of convertible preferred stock warrant liability   2,279
Changes in assets and liabilities    
Prepaid expenses and other assets 7 (2,030)
Accounts payable (119) (71)
Accrued liabilities and other liabilities 582 377
Net cash used in operating activities (52,917) (28,611)
Cash flows from investing activities    
Purchase of property and equipment (4) (600)
Net cash used in investing activities (4) (600)
Cash flows from financing activities    
Proceeds from issuance of common stock in initial public offering, net of issuance costs   132,138
Proceeds from issuance of common stock in follow-on offering, net of issuance costs 80,208  
Proceeds from issuance of convertible preferred stock, net of issuance costs   64,793
Proceeds from exercise of convertible preferred stock warrants   570
Proceeds from issuance of equity awards in connection with equity incentive plans 161 4
Net cash provided by financing activities 80,369 197,505
Net increase in cash and cash equivalents 27,448 168,294
Cash and cash equivalents at beginning of period 170,566 13,288
Cash and cash equivalents at end of period $ 198,014 181,582
Conversion of preferred stock call option liability [Member]    
Supplemental disclosure of noncash items    
Conversion of liability to additional paid in capital   9,581
Conversion of preferred stock warrant liability [Member]    
Supplemental disclosure of noncash items    
Conversion of liability to additional paid in capital   2,752
Conversion of preferred stock to common stock [Member]    
Supplemental disclosure of noncash items    
Conversion to common stock and additional paid in capital   $ 122,290